Asma Jouini
About Asma Jouini
Asma Jouini is a Senior Analyst specializing in Market Access, currently working at Putnam PHMR in Tunisia. She has a background in medical biotechnology and extensive experience in pricing analyses and market access strategies across various therapeutic areas.
Current Role at Putnam Associates
Asma Jouini serves as a Senior Analyst in Market Access at Putnam PHMR, a position she has held since 2023. In this role, she focuses on developing market access strategies and conducting analyses that inform pricing and reimbursement pathways for pharmaceuticals. Her expertise includes preparing submission packages for early scientific advice with various regulatory bodies, enhancing the company's capabilities in navigating complex market environments.
Previous Experience in Market Access
Prior to her current role, Asma Jouini worked as a Market Access Analyst II at Putnam PHMR for three months in 2022. Her experience also includes a position at the Institut Pasteur de Tunis, where she worked in molecular biology for five months in 2017. Additionally, she held a role in quality management at Clinique Ophtalmologique de Tunis in 2020, further diversifying her professional background in healthcare.
Educational Background and Specializations
Asma Jouini has a strong educational foundation in medical biotechnology and health management. She earned a Bachelor of Applied Science in Medical Biotechnology with a focus on Cell Therapy from the Tunisian Higher Institute of Medical Technologies, completing her studies from 2014 to 2017. She furthered her education with an Engineer's degree in Cellular and Molecular Biology from Honoris United Universities between 2017 and 2020, and obtained the European Market Access University Diploma from Aix-Marseille University in 2021. In 2023, she completed a course in Leadership and Management in Health at the University of Washington.
Key Therapeutic Areas of Expertise
Asma Jouini specializes in several key therapeutic areas, including oncology, dermatology, ophthalmology, auto-immune diseases, chronic diseases, and rare diseases. Her work involves conducting comprehensive benchmark pricing analyses and landscape assessments, which support strategic recommendations for evidence generation in the pharmaceutical industry. This specialization allows her to contribute effectively to market access strategies in various regions.
Contributions to Pharmaceutical Market Access
In her professional capacity, Asma Jouini has developed training materials that outline recent evidence requirements and pricing and reimbursement pathways for medicines in key markets, including the EU5, Canada, and APAC. She has a geographic focus on market access strategies, which includes preparing submission packages for early scientific advice with regulatory bodies such as NICE in the UK, HAS in France, and G-BA in Germany.